ChiRex

ChiRex was a premier contract development and manufacturing organization (CDMO) that specialized in the production of chiral pharmaceutical intermediates and active pharmaceutical ingredients. The company gained international recognition for its advanced capabilities in asymmetric synthesis and catalytic technologies, which allowed for the efficient production of single-isomer drugs. Headquartered in the United States with major manufacturing operations in the United Kingdom, ChiRex served a broad client base of global pharmaceutical companies. In 2000, the company was acquired by Rhodia for approximately 510 million USD to enhance its life sciences portfolio. Following subsequent mergers and acquisitions, the expertise and assets of ChiRex became part of Solvay. The company's legacy remains significant in the field of specialized chemical synthesis for healthcare applications.